Stock Analyst Rating Reiterations → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action All Ratings Strong Buy Buy Hold Sell Rating Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsACRVAcrivon Therapeutics Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$9.18-3.4% $20.00Buy ➝ BuyALGNAlign Technology Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$303.21-3.4%$355.00 ➝ $375.00Overweight ➝ OverweightALITAlight Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$8.98-2.0% $14.00Outperform ➝ OutperformAMEDAmedisys Reiterated byCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy rating$90.91-0.2% $101.00Neutral ➝ NeutralAMZNAmazon.com Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$170.92-3.2%$200.00 ➝ $200.00Outperform ➝ OutperformCAPRCapricor Therapeutics Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$5.01-0.6% $40.00Buy ➝ Buy Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CCSCentury Communities Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. MccanlessSubscribe to MarketBeat All Access for the recommendation accuracy rating$78.25-4.7% $82.00Underperform ➝ UnderperformCFFNCapitol Federal Financial Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$4.89-5.6%$7.00 ➝ $6.00Market Perform ➝ Market PerformCHCOCity Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$105.61-0.5%$100.00 ➝ $110.00Market Perform ➝ Market PerformCMECME Group Reiterated byRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy rating$213.01+0.2%$185.00 ➝ $187.00Sell ➝ SellCMGChipotle Mexican Grill Reiterated byOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating$2,995.00+2.3%$2,825.00 ➝ $3,300.00Outperform ➝ OutperformCNKCinemark Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$17.37-1.9% $23.00Outperform ➝ OutperformCOOPMr. Cooper Group Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$79.31-2.9%$86.00 ➝ $92.00Outperform ➝ OutperformCOURCoursera Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$11.74-1.5%$25.00 ➝ $25.00Outperform ➝ OutperformCVBFCVB Financial Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$16.56-3.1% $19.00Neutral ➝ NeutralCVNACarvana Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$73.06-3.0%$60.00 ➝ $80.00Neutral ➝ NeutralDBDDiebold Nixdorf Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$31.56-4.2% $40.00Neutral ➝ NeutralELEstée Lauder Companies Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingD. TelseySubscribe to MarketBeat All Access for the recommendation accuracy rating$144.09-2.2%$155.00 ➝ $155.00Market Perform ➝ Market PerformENVXEnovix Reiterated byCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy rating$5.79-3.8% $30.00Overweight ➝ OverweightETDEthan Allen Interiors Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$28.73-14.0%$30.00 ➝ $30.00Market Perform ➝ Market PerformFUBOfuboTV Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.36-1.4% $5.00Outperform ➝ OutperformGANXGain Therapeutics Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingR. SelvarajuSubscribe to MarketBeat All Access for the recommendation accuracy rating$3.04-4.7% $9.00Buy ➝ BuyHCPHashiCorp Reiterated byTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy rating$32.90+4.7%$27.00 ➝ $35.00Buy ➝ HoldHCPHashiCorp Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$32.90+4.7%Buy ➝ HoldHCPHashiCorp Reiterated byScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy rating$32.90+4.7%$31.00 ➝ $35.00Sector Outperform ➝ Sector PerformLRCXLam Research Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$896.03+1.3% $1,030.00Buy ➝ BuyLRCXLam Research Reiterated byCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingC. MuseSubscribe to MarketBeat All Access for the recommendation accuracy rating$896.03+1.3% $1,100.00Neutral ➝ NeutralLTRNLantern Pharma Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$5.35-0.6%NeutralMCMoelis & Company Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$49.68-8.0%$58.00 ➝ $54.00Market Perform ➝ Market PerformMDBMongoDB Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$360.11-2.5% $465.00Buy ➝ BuyMETAMeta Platforms Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$430.75-12.7%UnderperformMETAMeta Platforms Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$430.75-12.7%$600.00 ➝ $545.00Overweight ➝ OverweightMTHMeritage Homes Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. MccanlessSubscribe to MarketBeat All Access for the recommendation accuracy rating$160.65+3.9% $148.00Underperform ➝ UnderperformMXLMaxLinear Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$21.72+3.8% $25.00Buy ➝ BuyNOWServiceNow Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$700.68-6.1% $900.00Buy ➝ BuyNTBBank of N.T. Butterfield & Son Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$33.94+0.8%$34.00 ➝ $38.00Overweight ➝ OverweightORLYO'Reilly Automotive Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$1,025.70-6.1% $1,100.00Neutral ➝ NeutralPFCPremier Financial Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$20.07-1.5%$25.00 ➝ $23.00Market Perform ➝ Market PerformPFSIPennyMac Financial Services Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$86.02-6.6% $110.00Outperform ➝ OutperformPIImpinj Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$141.72+17.2%$130.00 ➝ $150.00Overweight ➝ OverweightYour Money is Not Safe (Ad)Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOWPPBIPacific Premier Bancorp Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$22.16-2.6% $25.00Neutral ➝ NeutralPYCRPaycor HCM Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$17.42-0.2% $42.00Buy ➝ BuyRBBRBB Bancorp Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$18.47-0.2%$20.00 ➝ $22.00Market Perform ➝ Market PerformSAGESage Therapeutics Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$14.63+4.5%HoldSEICSEI Investments Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$65.49-1.7%$72.00 ➝ $74.00Market Perform ➝ Market PerformSNBRSleep Number Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$13.64+0.5% $13.50Neutral ➝ NeutralSYBTStock Yards Bancorp Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$46.42-3.5%$53.00 ➝ $54.00Market Perform ➝ Market PerformTERTeradyne Reiterated byCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingC. MuseSubscribe to MarketBeat All Access for the recommendation accuracy rating$107.85+7.1% $110.00Neutral ➝ NeutralTPHTri Pointe Homes Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. MccanlessSubscribe to MarketBeat All Access for the recommendation accuracy rating$35.81-1.0% $35.00Neutral ➝ NeutralTYLTyler Technologies Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$443.71+5.9% $500.00Buy ➝ BuyVKTXViking Therapeutics Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$65.98+1.4% $90.00Buy ➝ BuyXOMAXOMA Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$25.20-1.7% $74.00Buy ➝ BuyAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:12 AM ET. Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage. Email Address Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Alphabet (Google) Amazon Apple Meta (Facebook) Microsoft Netflix Nvidia Tesla Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
